Fidaxomicin | Interleukin Related interleukin-related.com

Product Name :
Fidaxomicin

Search keywords :
PAR

drugId :
null

Target Vo:
Bacterial DNA-directed RNA polymerase

Target Vo Short Name :
RNAP

Moa_Name:
Bacterial DNA-directed RNA polymerase inhibitors

First Approval Country :
United States

First Approval Date Filter:
2011

Origin Company_Name :
Cubist Pharmaceuticals

Active Company_Name :
Astellas Pharma Inc

Active Indication_Name:
Clostridium Infections

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JNK2 Antibody
Tyrosine Hydroxylase Antibody
Hsp70 1A Antibody (YA727): Hsp70 1A Antibody (YA727) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to Hsp70 1A (1D9). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts